Dataset from A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008610
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the present study is to investigate the safety of BI 10773 treatment in patients
with Type 2 Diabetes Mellitus and high cardiovascular risk.
创建时间：
2026-02-18
